Antiviral Agents (pharmacokinetics) < Antiviral Agents (pharmacology) < Antiviral Agents (supply & distribution)

Facettes : AffPays.f Mesh.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 65.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000069 (2002)	Terrence M. Tumpey [États-Unis] ; Adolfo García-Sastre [États-Unis] ; Andrea Mikulasova [États-Unis] ; Jeffery K. Taubenberger [États-Unis] ; David E. Swayne [États-Unis] ; Peter Palese [États-Unis] ; Christopher F. Basler [États-Unis]	Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus
000153 (2004)	Frederick G. Hayden [États-Unis]	Pandemic influenza: is an antiviral response realistic?
000154 (2004)	C. Ruef	A new influenza pandemic-unprepared for a big threat?
000169 (2005)	Ruth Kandel [États-Unis] ; Kevan L. Hartshorn	Novel strategies for prevention and treatment of influenza.
000206 (2005)	Neil M. Ferguson [Royaume-Uni] ; Derek A T. Cummings ; Simon Cauchemez ; Christophe Fraser ; Steven Riley ; Aronrag Meeyai ; Sopon Iamsirithaworn ; Donald S. Burke	Strategies for containing an emerging influenza pandemic in Southeast Asia.
000372 (2006)	M. A. Rameix-Welti ; F. Agou ; P. Buchy ; S. Mardy ; J. T. Aubin ; M. Véron ; S. Van Der Werf ; N. Naffakh	Natural Variation Can Significantly Alter the Sensitivity of Influenza A (H5N1) Viruses to Oseltamivir▿
000395 (2006)	Ingo Stock [Allemagne]	[Human influenza].
000464 (2007)	Marc Lipsitch [États-Unis] ; Ted Cohen [États-Unis] ; Megan Murray [États-Unis] ; Bruce R. Levin [États-Unis]	Antiviral Resistance and the Control of Pandemic Influenza
000581 (2007)	Hui-Ling Yen [États-Unis] ; Natalia A. Ilyushina [États-Unis] ; Rachelle Salomon [États-Unis] ; Erich Hoffmann [États-Unis] ; Robert G. Webster [États-Unis] ; Elena A. Govorkova [États-Unis]	Neuraminidase Inhibitor-Resistant Recombinant A/Vietnam/1203/04 (H5N1) Influenza Viruses Retain Their Replication Efficiency and Pathogenicity In Vitro and In Vivo▿
000597 (2007)	Susy Hota [Canada] ; Allison Mcgeer	Antivirals and the control of influenza outbreaks.
000613 (2007)	Tatiana Betakova [Slovaquie]	M2 protein-a proton channel of influenza A virus.
000615 (2007)	Mark Von Itzstein [Australie]	The war against influenza: discovery and development of sialidase inhibitors.
000625 (2008)	Jih-Hui Lin [Taïwan] ; Shu-Chun Chiu ; Cheng-Hao Lee ; Yung-Jui Su ; Han-Chuan Tsai ; Yen-Tzu Peng ; Ho-Seng Wu	Genetic and antigenic analysis of epidemic influenza viruses isolated during 2006-2007 season in Taiwan.
000634 (2007)	Anice C. Lowen [États-Unis] ; Peter Palese	Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic.
000679 (2008)	Natalia A. Ilyushina [États-Unis, Russie] ; Elena A. Govorkova [États-Unis] ; Thomas E. Gray [États-Unis] ; Nicolai V. Bovin [Russie] ; Robert G. Webster [États-Unis]	Human-Like Receptor Specificity Does Not Affect the Neuraminidase-Inhibitor Susceptibility of H5N1 Influenza Viruses
000680 (2008)	David S. Fedson [France]	Confronting an influenza pandemic with inexpensive generic agents: can it be done?
000686 (2008)	Arnold S. Monto [États-Unis] ; Richard J. Whitley	Seasonal and pandemic influenza: a 2007 update on challenges and solutions.
000701 (2008)	James M. Mccaw [Australie] ; James G. Wood [Australie] ; Christopher T. Mccaw [Australie] ; Jodie Mcvernon [Australie]	Impact of Emerging Antiviral Drug Resistance on Influenza Containment and Spread: Influence of Subclinical Infection and Strategic Use of a Stockpile Containing One or Two Drugs
000713 (2008)	Edbert B. Hsu [États-Unis] ; Michael G. Millin	A hospital-based strategy for setting priorities for antiviral prophylaxis during an influenza pandemic.
000825 (2009)	A. Melidou [Grèce] ; V. Kyriazopoulou ; E. Diza ; S. Alexiou ; Y. Pierroutsakos	Antiviral resistance of influenza A (H3N2) strains isolated in northern Greece between 2004 and 2007.
000864 (2009)	J P Wong [Canada] ; M E Christopher ; S. Viswanathan ; X. Dai ; A M Salazar ; L-Q Sun ; M. Wang	Antiviral role of toll-like receptor-3 agonists against seasonal and avian influenza viruses.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiviral Agents (pharmacology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiviral Agents (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiviral Agents (pharmacology)
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021